fda semaglutide news 🎉Exciting that is now approved for MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Hims & Hers stock falls

GLP-1 medications like Ozempic, Wegovy, and Mounjaro have become almost impossible to escape

Standard course: 1-2 times per week for 4-8 weeks

This may reduce, though not eliminate, the risk of rebound weight gain

For example, lets say the GLP-1 drug you want to take isnt covered by Medicaid

However, it is produced in a facility that may process these allergens

Our answer is rarely stop. Its usually some version of: Stay on the therapeutic dose for at least 3 to 6 months past goal weight to consolidate the loss Step down carefully (if appropriate), watch the scale, and make adjustments as needed Extend the interval for patients maintaining well on any dose, high or low